Large and complex ventral hernia repair using “components separation technique” without mesh results in a high recurrence rate

2015 ◽  
Vol 209 (1) ◽  
pp. 170-179 ◽  
Author(s):  
Nicholas J. Slater ◽  
Harry van Goor ◽  
Robert P. Bleichrodt
2016 ◽  
Vol 76 (6) ◽  
pp. 674-679 ◽  
Author(s):  
Brinkley K. Sandvall ◽  
Daniel W. Suver ◽  
Hakim K. Said ◽  
David W. Mathes ◽  
Peter C. Neligan ◽  
...  

2018 ◽  
Vol 84 (3) ◽  
pp. 433-437 ◽  
Author(s):  
Thomas O. Muse ◽  
Brittany A. Zwischenberger ◽  
M. Troy Miller ◽  
Daniel A. Borman ◽  
Daniel L. Davenport ◽  
...  

Complex ventral hernias remain a challenge for general surgeons despite advances in minimally invasive surgical techniques. This study compares outcomes following Rives-Stoppa (RS) repair, components separation technique with mesh (CST-M) or without mesh (CST), and endoscopic components separation technique (ECST). A retrospective review of patients undergoing open ventral hernia repair between 2006 and 2011 was performed. Analysis included patient demographics, surgical site occurrences, hernia recurrence, hospital readmission, and mortality. The search was limited to open repairs, specifically the RS, CST-M, CST, and ECST with mesh techniques. A total of 362 patients underwent repair with RS (66), CST-M (126), CST (117), or ECST (53). The groups were demographically similar. ECST was more frequently used for patients with a history of two or more recurrences ( P < 0.001). The RS method had the lowest rate of recurrence (9.1%) compared with CST and CST-M with 28 and 25 per cent recurrences, respectively ( P = 0.011). The RS recurrence rate was not significantly different than ECST (15%). There were no significant differences between groups for surgical site occurrences ( P = 0.305), hospital read-mission ( P = 0.288), or death ( P = 0.197). When components separation is necessary for complex ventral hernia repair, ECST is a viable option without added morbidity or mortality.


2012 ◽  
Vol 2012 ◽  
pp. 1-5 ◽  
Author(s):  
William W. Hope ◽  
Devan Griner ◽  
Ashley Adams ◽  
W. Borden Hooks ◽  
Thomas V. Clancy

Background. To evaluate the use, indications, and short-term outcomes for human acellular dermis. Methods. We retrospectively reviewed patients having human acellular dermis placed for ventral hernia repair from January 2008 through October 2009. Demographic information, operative details, and outcomes of patients with and without recurrences were compared; a P value <0.05 was considered significant. Results. 115 patients met inclusion criteria. The average age was 60 years (range, 24–89). The technique of repair included primary repair with overlay of mesh in 76%, bridge repair in 13%, and underlay in 11%. Average cost of mesh per operation was $3,709 (range $191–10,630). Open repairs were performed in 90% of patients with addition of component separation in 12%. At an average of 13 months, 58 patients were available for followup (50%), with a 47% recurrence rate. The morbidity rate was 48% and the mortality rate was 2%. Technique of repair was the only significant risk factor for recurrence with bridge repairs associated with a higher rate of recurrence (). Conclusions. The use of biologic grafts for ventral hernia repair is becoming more popular especially in clean cases. Although followup is limited, there remains a high recurrence rate associated with the use of human acellular dermis.


Sign in / Sign up

Export Citation Format

Share Document